Mariya M. Kucherenko

Potsdamer Str. 58
Berlin, BE 10785, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Defining HFpEF in rodents: a systematic review.

Defining HFpEF in rodents: a systematic review.

Journal: Cardiovascular research

Published: February 06, 2025

Remodelling of the endothelial extracellular matrix promotes smooth muscle cell hyperplasia in pulmonary hypertension due to left heart disease.

Remodelling of the endothelial extracellular matrix promotes smooth muscle cell hyperplasia in pulmonary hypertension due to left heart disease.

Journal: Cardiovascular research

Published: January 21, 2025

Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension.

Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension.

Journal: Circulation

Published: June 14, 2024

Ultrasonographic assessment of pulmonary and Central venous congestion in experimental heart failure.

Ultrasonographic assessment of pulmonary and Central venous congestion in experimental heart failure.

Journal: American journal of physiology. Heart and circulatory physiology

Published: December 15, 2023

Identification of pulmonary artery stiffening due to left heart disease by ultrasonography.

Identification of pulmonary artery stiffening due to left heart disease by ultrasonography.

Journal: Cardiovascular research

Published: June 02, 2023

RUNX2 is stabilised by TAZ and drives pulmonary artery calcification and lung vascular remodelling in pulmonary hypertension due to left heart disease.

RUNX2 is stabilised by TAZ and drives pulmonary artery calcification and lung vascular remodelling in pulmonary hypertension due to left heart disease.

Journal: The European respiratory journal

Published: May 19, 2023

Pulmonary hypertension: Linking inflammation and pulmonary arterial stiffening.

Pulmonary hypertension: Linking inflammation and pulmonary arterial stiffening.

Journal: Frontiers in immunology

Published: June 01, 2022

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats.

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats.

Journal: Journal of visualized experiments : JoVE

Published: March 21, 2022

Elastin stabilization prevents impaired biomechanics in human pulmonary arteries and pulmonary hypertension in rats with left heart disease.

Elastin stabilization prevents impaired biomechanics in human pulmonary arteries and pulmonary hypertension in rats with left heart disease.

Journal: Nature communications

Published: September 14, 2021

Exocyst-mediated membrane trafficking of the lissencephaly-associated ECM receptor dystroglycan is required for proper brain compartmentalization.

Exocyst-mediated membrane trafficking of the lissencephaly-associated ECM receptor dystroglycan is required for proper brain compartmentalization.

Journal: eLife

Published: October 11, 2020

Profiling of the muscle-specific dystroglycan interactome reveals the role of Hippo signaling in muscular dystrophy and age-dependent muscle atrophy.

Profiling of the muscle-specific dystroglycan interactome reveals the role of Hippo signaling in muscular dystrophy and age-dependent muscle atrophy.

Journal: BMC medicine

Published: September 11, 2019

Therapeutic Targeting of High-Mobility Group Box-1 in Pulmonary Arterial Hypertension.

Therapeutic Targeting of High-Mobility Group Box-1 in Pulmonary Arterial Hypertension.

Journal: American journal of respiratory and critical care medicine

Published: April 03, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026